Send to

Choose Destination
See comment in PubMed Commons below
Case Rep Med. 2012;2012:358024. doi: 10.1155/2012/358024. Epub 2012 Oct 9.

Thrombocytopenia in the setting of hemodialysis using biocompatible membranes.

Author information

School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.


Thrombocytopenia is a known potential side effect of hemodialysis, however, it is rarely seen in patients who undergo hemodialysis using biocompatible membranes. This case demonstrates hemodialysis-associated thrombocytopenia with use of biocompatible dialysis membranes that expose blood directly to polysulfone. The thrombocytopenia resolved in this patient when the dialysis membrane was changed to a biocompatible model with a polyethylene glycol barrier layer preventing direct interaction between patient blood and polysulfone. The calculated Naranjo ADR score of 9 indicates a highly probable adverse reaction.

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center